Tonix Pharmaceuticals Holding (OTCBB: TNXP) develops innovative prescription medications for challenging disorders of the central nervous system. Targeting conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians, TONIX’s core technology improves the quality of sleep in patients with chronic pain syndromes. TONIX’s lead products are designed to be fundamental advances in sleep hygiene and pain management and to be safer and more effective than currently available treatments. For more information visit the company’s Web site at www.tonixpharma.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below: